Search Results - "Malick, Waqas"

Clinical Trial Design for Lipoprotein(a)-Lowering Therapies: JACC Focus Seminar 2/3 by Malick, Waqas A, Goonewardena, Sascha N, Koenig, Wolfgang, Rosenson, Robert S

“…Lipoprotein(a) [Lp(a)] is a source of residual risk in patients with atherosclerotic cardiovascular disease (ASCVD). Clinical trials of fully human monoclonal…”
Get full text

Severe hypertriglyceridemia: Existing and emerging therapies by Malick, Waqas A., Do, Ron, Rosenson, Robert S.

“…Severe hypertriglyceridemia (sHTG), defined as a triglyceride (TG) concentration ≥ 500 mg/dL (≥ 5.7 mmol/L) is an important risk factor for acute pancreatitis…”
Get full text

Prediction of Venous Thromboembolism in Diverse Populations Using Machine Learning and Structured Electronic Health Records by Chen, Robert, Petrazzini, Ben Omega, Malick, Waqas A, Rosenson, Robert S, Do, Ron

“…Venous thromboembolism (VTE) is a major cause of morbidity and mortality worldwide. Current risk assessment tools, such as the Caprini and Padua scores and…”
Get full text

Primary Prevention of Subclinical Atherosclerosis in Young Adults: JACC Review Topic of the Week by Devesa, Ana, Ibanez, Borja, Malick, Waqas A, Tinuoye, Elizabeth O, Bustamante, Jessica, Peyra, Carlos, Rosenson, Robert S, Bhatt, Deepak L, Stone, Gregg W, Fuster, Valentin

“…There is growing evidence that the atherosclerotic process that leads to symptomatic cardiovascular disease (CVD) starts at an early age. In young adults,…”
Get full text

Familial Hypercholesterolemia: Challenges for a High-Risk Population: JACC Focus Seminar 1/3 by Choi, Daein, Malick, Waqas A, Koenig, Wolfgang, Rader, Daniel J, Rosenson, Robert S

“…The availability of statins, ezetimibe, and PCSK9 inhibitors has significantly improved the prognosis of familial hypercholesterolemia (FH). However, a great…”
Get full text

Clinical Trial Design for Triglyceride-Rich Lipoprotein-Lowering Therapies: JACC Focus Seminar 3/3 by Malick, Waqas A, Waksman, Ori, Do, Ron, Koenig, Wolfgang, Pradhan, Aruna D, Stroes, Erik S G, Rosenson, Robert S

“…Triglyceride-rich lipoproteins (TRLs) are a source of residual risk in patients with atherosclerotic cardiovascular disease, and are indirectly correlated with…”
Get full text

Long-term outcomes after Roux-en-Y gastric bypass: 10- to 13-year data by Obeid, Nabeel R., M.D, Malick, Waqas, B.S, Concors, Seth J., M.D, Fielding, George A., M.D, Kurian, Marina S., M.D, Ren-Fielding, Christine J., M.D

“…Abstract Background Short- and mid-term data on Roux-en-Y gastric bypass (RYGB) indicate sustained weight loss and improvement in co-morbidities. Few long-term…”
Get full text

Sex-Based Differences in Revascularization Outcomes: Is It Time for a Dedicated Randomized Trial in Women? by Malick, Waqas A, Soriano, Kevin, Stone, Gregg W

Get full text

Exome sequence analysis identifies rare coding variants associated with a machine learning-based marker for coronary artery disease by Petrazzini, Ben Omega, Forrest, Iain S., Rocheleau, Ghislain, Vy, Ha My T., Márquez-Luna, Carla, Duffy, Áine, Chen, Robert, Park, Joshua K., Gibson, Kyle, Goonewardena, Sascha N., Malick, Waqas A., Rosenson, Robert S., Jordan, Daniel M., Do, Ron

“…Coronary artery disease (CAD) exists on a spectrum of disease represented by a combination of risk factors and pathogenic processes. An in silico score for CAD…”
Get full text

ABCA1 Deficiency: A Rare Cause of Premature Coronary Artery Disease by Malick, Waqas A, Schaefer, Ernst J, Hegele, Robert A, Rosenson, Robert S

“…ATP-binding cassette transporter A1 (ABCA1) deficiency results in very low high-density lipoprotein cholesterol levels. Complete ABCA1 deficiency, or Tangier…”
Get full text

Predictors of Survival for Patients with Acute Decompensated Heart Failure Requiring Extra-Corporeal Membrane Oxygenation Therapy by Garan, A Reshad, Malick, Waqas A, Habal, Marlena, Topkara, Veli K, Fried, Justin, Masoumi, Amirali, Hasan, Aws K, Karmpaliotis, Dimitri, Kirtane, Ajay, Yuzefpolskaya, Melana, Farr, Maryjane, Naka, Yoshifumi, Burkhoff, Dan, Colombo, Paolo C, Kurlansky, Paul, Takayama, Hiroo, Takeda, Koji

“…Chronic systolic heart failure (HF) with acute decompensation can result in cardiogenic shock (CS) requiring short-term mechanical circulatory support. We…”
Get full text

Weight loss outcomes among patients referred after primary bariatric procedure by Obeid, Nabeel R., M.D, Malick, Waqas, B.S, Baxter, Andrew, M.D, Molina, Bianca, M.D, Schwack, Bradley F., M.D, Kurian, Marina S., M.D, Ren-Fielding, Christine J., M.D, Fielding, George A., M.D

“…Abstract Background Bariatric patients may not always obtain long-term care by their primary surgeon. Our aim was to evaluate weight loss outcomes in patients…”
Get full text

Diagnostic Value of Coronary Artery Calcium Scoring in Low-Intermediate Risk Patients Evaluated in the Emergency Department for Acute Coronary Syndrome by Fernandez-Friera, Leticia, MD, Garcia-Alvarez, Ana, MD, Bagheriannejad-Esfahani, Fatemeh, MD, Malick, Waqas, BS, Mirelis, Jesus G., MD, Sawit, Simonette T., MD, Fuster, Valentin, MD, PhD, Sanz, Javier, MD, Garcia, Mario J., MD, Hermann, Luke K., MD

“…Early and accurate triage of patients with possible ischemic chest pain remains challenging in the emergency department because current risk stratification…”
Get full text

Abstract 17162: High Lp(a) is Associated With Activation of the Arachidonic Acid Pathway by Malick, Waqas, Mar, Phyu, Goonewardena, Sascha N, Rosenson, Robert S

“…Abstract only Introduction: High lipoprotein(a) [Lp(a)] is associated with increased platelet aggregation, inflammation and cardiovascular events. Eicosanoids…”
Get full text

Familial Hypercholesterolemia: Challenges for a High-Risk Population by Choi, Daein, Malick, Waqas A., Koenig, Wolfgang, Rader, Daniel J., Rosenson, Robert S.

“…The availability of statins, ezetimibe, and PCSK9 inhibitors has significantly improved the prognosis of familial hypercholesterolemia (FH). However, a great…”
Get full text

Clinical Trial Design for Lipoprotein(a)-Lowering Therapies by Malick, Waqas A., Goonewardena, Sascha N., Koenig, Wolfgang, Rosenson, Robert S.

“…Lipoprotein(a) [Lp(a)] is a source of residual risk in patients with atherosclerotic cardiovascular disease (ASCVD). Clinical trials of fully human monoclonal…”
Get full text

Abstract 4119535: Aspirin Use and Cardiovascular Disease Incidence in Adults with High Lipoprotein(a): A Multi-Cohort Study by Colantonio, Lisandro, Wang, Zhixin, Ghazi, Lama, Alanaeme, Chibuike, Christenson, Ashley, Dubal, Medha, Malick, Waqas, Levitan, Emily, Rosenson, Robert, Bittner, Vera

“…Abstract only Introduction: There is an active debate about who may benefit from taking aspirin to reduce their incidence of cardiovascular disease (CVD). Some…”
Get full text

Characterization of Myocardial Injury in Patients With COVID-19 by Giustino, Gennaro, Croft, Lori B., Stefanini, Giulio G., Bragato, Renato, Silbiger, Jeffrey J., Vicenzi, Marco, Danilov, Tatyana, Kukar, Nina, Shaban, Nada, Kini, Annapoorna, Camaj, Anton, Bienstock, Solomon W., Rashed, Eman R., Rahman, Karishma, Oates, Connor P., Buckley, Samantha, Elbaum, Lindsay S., Arkonac, Derya, Fiter, Ryan, Singh, Ranbir, Li, Emily, Razuk, Victor, Robinson, Sam E., Miller, Michael, Bier, Benjamin, Donghi, Valeria, Pisaniello, Marco, Mantovani, Riccardo, Pinto, Giuseppe, Rota, Irene, Baggio, Sara, Chiarito, Mauro, Fazzari, Fabio, Cusmano, Ignazio, Curzi, Mirko, Ro, Richard, Malick, Waqas, Kamran, Mazullah, Kohli-Seth, Roopa, Bassily-Marcus, Adel M., Neibart, Eric, Serrao, Gregory, Perk, Gila, Mancini, Donna, Reddy, Vivek Y., Pinney, Sean P., Dangas, George, Blasi, Francesco, Sharma, Samin K., Mehran, Roxana, Condorelli, Gianluigi, Stone, Gregg W., Fuster, Valentin, Lerakis, Stamatios, Goldman, Martin E.

“…BACKGROUNDMyocardial injury is frequent among patients hospitalized with coronavirus disease-2019 (COVID-19) and is associated with a poor prognosis. However,…”
Get full text

Abstract 18686: Distinct Proteomic Signatures in Subjects With Elevated Lipoprotein(a) Levels With and Without Coronary Artery Disease by Goonewardena, Sascha N, Malick, Waqas, DAMODARAN, DILNA, Katragadda, Jay Krishna, Grushko, Olga, Cady, Gillian, Murthy, Venkatesh L, Rosenson, Robert S

“…Abstract only Introduction: Genetic and observational studies suggest a causal link between an elevated lipoprotein(a) [Lp(a)] and coronary artery disease…”
Get full text

Clinical Trial Design for Triglyceride-Rich Lipoprotein-Lowering Therapies by Malick, Waqas A., Waksman, Ori, Do, Ron, Koenig, Wolfgang, Pradhan, Aruna D., Stroes, Erik S.G., Rosenson, Robert S.

“…Triglyceride-rich lipoproteins (TRLs) are a source of residual risk in patients with atherosclerotic cardiovascular disease, and are indirectly correlated with…”
Get full text